The Astrocytic Endothelin System and Amyotrophic Lateral Sclerosis (ALS)

The goal is to examine whether increased ET-1 production by astrocytes correlates with ALS pathology and progression, and whether endothelin receptor inhibition represents a novel therapeutic target.